Skip to main content
MEDICO REMEDIES LIMITED logo

MEDICO REMEDIES LIMITED — Investor Relations & Filings

Ticker · MEDICO ISIN · INE630Y01024 LEI · 335800TQLW6NX1TXF590 BSE.NS Manufacturing
Open in API
Filings indexed 182 across all filing types
Latest filing 2026-05-21 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS MEDICO

About MEDICO REMEDIES LIMITED

https://medicoremedies.com/

Medico Remedies Limited specializes in the manufacture and marketing of a diverse range of pharmaceutical formulations. The company produces various dosage forms, including tablets, capsules, dry syrups, liquid orals, and ointments. Its product portfolio covers multiple therapeutic segments such as anti-infectives, vitamins, minerals, supplements, cardiovascular, and anti-diabetic medications. The organization operates manufacturing facilities equipped with modern technology to ensure compliance with international quality standards. Medico Remedies focuses on providing high-quality generic medicines and offers contract manufacturing services to global partners. With an emphasis on research and development, the company continuously expands its product pipeline to meet evolving healthcare needs. It maintains a significant presence in international markets, exporting products to various regions while adhering to stringent regulatory requirements.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Interim / Quarterly Report Classification · 85% confidence The document is an Indian stock‐exchange filing under SEBI LODR regulations announcing the outcome of a board meeting, approved audited standalone financial results for the quarter ended March 31, 2026 and for the year ended March 31, 2026, includes the auditor’s report and detailed financial statement tables. It is not a full Annual Report (10‐K), nor merely an earnings highlight (ER), but a detailed regulatory release of quarterly/annual financial results. Hence it fits the definition of an Interim/Quarterly Report (IR). FY 2026
2026-05-21 English
Please find enclosed
Audit Report / Information Classification · 80% confidence The document is not a full Annual Report (10-K) but a regulatory disclosure under SEBI Listing Regulations that includes: (1) the outcome of the Board meeting approving the audited standalone results; (2) a director’s declaration on the auditor’s opinion; (3) the Independent Auditor’s Report; and (4) the audited standalone financial results tables. This fits the “Audit Report / Information” category (Code: AR), as it chiefly contains the standalone audit report and audited financial statements (excluding a more comprehensive annual report). FY 2026
2026-05-21 English
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars ....
Regulatory Filings Classification · 85% confidence The document is a compliance disclosure to BSE and NSE under SEBI circulars regarding fund raising by issuance of debt securities by large entities. It confirms that the company does not meet the ‘Large Corporate’ criteria and provides prescribed details. It is not an actual financial report, not a notice of dividend, not a board change, and contains no substantive financial statements. It is a regulatory announcement required by the stock exchanges to comply with SEBI rules, fitting the fallback “Regulatory Filings” category.
2026-05-21 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of our Company at their meeting held ....
Interim / Quarterly Report Classification · 75% confidence The document is an outcome of the Board meeting under Indian SEBI LODR, enclosing the audited standalone financial results (P&L, balance data) for the quarter ended 31 March 2026 (and annual year-end figures), along with the auditor's report and declarations. It contains full financial statements rather than just highlights, and is not the full Annual Report but a periodic results filing. Thus it best fits the Interim/Quarterly Report category. FY 2026
2026-05-21 English
Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve 1. Audited Financial Results ....
Regulatory Filings Classification · 78% confidence The document is a notice to stock exchanges of an upcoming Board of Directors meeting date and agenda, specifically to consider and approve audited financial results. It is not the financial results themselves (no actual results are included), nor is it a change in board composition, dividend, or request for votes. It is not a proxy or presentation, but a generic regulatory announcement. Therefore, it falls under the broad “Regulatory Filings” category (RNS).
2026-05-15 English
Action(s) taken or orders passed
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding an action taken by regulatory authorities under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It details the receipt of a Show Cause Notice (SoP Notice) for alleged non-compliance, the filing and rejection of waiver applications, payment of fines, and compliance status. The document references regulatory actions and compliance but does not contain financial statements or detailed financial performance data. It is a regulatory announcement about enforcement action and compliance status rather than a financial report or earnings release. The document length is 4244 characters, which is relatively short and focused on regulatory disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance disclosures that do not fit other specific categories.
2026-04-16 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.